Spark Investment Management’s Coherus Oncology CHRS Stock Holding History

Spark Investment Management’s Portfolio CHRS Stock Details CHRS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-124,900	Closed	-$2.64M	–	782
2017 Q1	$2.64M	Buy	124,900 +104,300	+506%	+$2.57M	0.17%	200
2016 Q4	$579K	Sell	20,600 -64,300	-76%	-$1.8M	0.05%	453
2016 Q3	$2.27M	Sell	84,900 -100,500	-54%	-$2.74M	0.18%	168
2016 Q2	$3.13M	Buy	+185,400	New	+$3.48M	0.29%	102
2015 Q3	–	Sell	-9,367	Closed	-$270K	–	681
2015 Q2	$270K	Buy	+9,367	New	+$237K	0.04%	464

Other funds holding CHRS

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

KKRC

Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PHS

PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Spark Investment Management's CHRS Position: Q2 2017 in Review

Spark Investment Management sold out of Coherus Oncology (CHRS) in Q2 2017, closing a stake of 124,900 shares — an estimated $2.64M sold.

Spark Investment Management first reported a position in CHRS in Q2 2015 and held it in 5 quarters. The position peaked at $3.13M in Q2 2016. 106 funds tracked by Wall St. Rank hold CHRS as of Q2 2017.

Spark Investment Management reported no remaining Coherus Oncology position as of Q2 2017 after selling out during the quarter.
Spark Investment Management sold 124,900 Coherus Oncology shares in Q2 2017, an estimated $2.64M.
Spark Investment Management first reported a position in Coherus Oncology in Q2 2015 and held it in 5 quarters.
Spark Investment Management's Coherus Oncology position peaked at $3.13M in Q2 2016.
106 funds tracked by Wall St. Rank held Coherus Oncology as of Q2 2017.

Based on Spark Investment Management's 13F filing for Q2 2017, filed 27 Jul 2017.